Latest news
Loading news…
Exscientia
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Oxford, Oxfordshire, United Kingdom Founded 2012 251-500 employees For Profit
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
Exscientia was acquired by Recursion Pharmaceuticals in 2024 for $688M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Monthly Visits
Available in Pro Contacts
306
Patents
13
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- EXAI
- Exchange
- NASDAQ
- IPO date
- Oct 1, 2021
- Raised at IPO
- $305M
- Valuation at IPO
- $3B
- Delisted
- Nov 20, 2024
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 20
- Patents granted
- 13
- Trademarks
- 0
- Top patent class
- Organic Chemistry
Company Info
- Founded
- 2012
- Employees
- 251-500
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 247
- Events
- 1
- HQ
- Oxford, Oxfordshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Oct 1, 2021
- Closed
- Jan 1, 2024
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.4
- Trend (30d)
- 0
- Trend (90d)
- 2.2
- Last leadership hire
- Oct 17, 2023
- Last layoff mention
- May 21, 2024
Acquisitions by Exscientia
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Exscientia
Chief Commercial Officer
Chief Research Officer
Chief Informatics Officer
Chief Scientist Biologics AI
Co-Founder and CEO
Chief Designer
Chief Decision Scientist
VP Medicinal Chemistry
Chief Bioinformatician
Chief Operating Officer
Chief Quantitative Medicine Officer
EVP, Corporate Development
306
professional contacts at Exscientia
Contact execs at Exscientia →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Exscientia
Loading news…
FAQs about Exscientia
People who checked this page also checked these
Sectors Exscientia invests & acquires in
Browse the full Acquirezy directory.